CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
Saved in:
| Title: | CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. |
|---|---|
| Authors: | Yamamoto Y; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan., Sugimoto A; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Maruo K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Tsujio G; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Sera T; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kushiyama S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Nishimura S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kuroda K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Togano S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Eguchi S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Tanaka R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Amano R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Yashiro M; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. |
| Source: | PloS one [PLoS One] 2022 Apr 04; Vol. 17 (4), pp. e0266027. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35377900 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Sugimoto+A%22">Sugimoto A</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Maruo+K%22">Maruo K</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujio+G%22">Tsujio G</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Sera+T%22">Sera T</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kushiyama+S%22">Kushiyama S</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+S%22">Nishimura S</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kuroda+K%22">Kuroda K</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Togano+S%22">Togano S</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Eguchi+S%22">Eguchi S</searchLink>; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+R%22">Tanaka R</searchLink>; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+K%22">Kimura K</searchLink>; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Amano+R%22">Amano R</searchLink>; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ohira+M%22">Ohira M</searchLink>; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yashiro+M%22">Yashiro M</searchLink>; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2022 Apr 04; Vol. 17 (4), pp. e0266027. <i>Date of Electronic Publication: </i>2022 Apr 04 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35377900 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0266027 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0266027 Titles: – TitleFull: CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yamamoto Y – PersonEntity: Name: NameFull: Sugimoto A – PersonEntity: Name: NameFull: Maruo K – PersonEntity: Name: NameFull: Tsujio G – PersonEntity: Name: NameFull: Sera T – PersonEntity: Name: NameFull: Kushiyama S – PersonEntity: Name: NameFull: Nishimura S – PersonEntity: Name: NameFull: Kuroda K – PersonEntity: Name: NameFull: Togano S – PersonEntity: Name: NameFull: Eguchi S – PersonEntity: Name: NameFull: Tanaka R – PersonEntity: Name: NameFull: Kimura K – PersonEntity: Name: NameFull: Amano R – PersonEntity: Name: NameFull: Ohira M – PersonEntity: Name: NameFull: Yashiro M IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 04 Text: 2022 Apr 04 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 17 – Type: issue Value: 4 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |